Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55.2M
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
21.2M
-
Shares change
-
+3.65M
-
Total reported value, excl. options
-
$162M
-
Value change
-
+$28.9M
-
Put/Call ratio
-
0.26
-
Number of buys
-
33
-
Number of sells
-
-22
-
Price
-
$7.62
Significant Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q1 2022
78 filings reported holding VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value as of Q1 2022.
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.2M shares
of 55.2M outstanding shares and own 38.43% of the company stock.
Largest 10 shareholders include TRV GP III, LLC (6.39M shares), EcoR1 Capital, LLC (3.56M shares), ARMISTICE CAPITAL, LLC (2M shares), VANGUARD GROUP INC (1.93M shares), Erste Asset Management GmbH (1.22M shares), BVF INC/IL (1.19M shares), D. E. Shaw & Co., Inc. (636K shares), FEDERATED HERMES, INC. (625K shares), BlackRock Inc. (514K shares), and JPMORGAN CHASE & CO (350K shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.